CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.
Marshall AD, Bailey CG, Champ K, Vellozzi M, O'Young P, Metierre C, Feng Y, Thoeng A, Richards AM, Schmitz U, Biro M, Jayasinghe R, Ding L, Anderson L, Mardis ER, Rasko JEJ.
Marshall AD, et al.
Oncogene. 2017 Jul 20;36(29):4100-4110. doi: 10.1038/onc.2017.25. Epub 2017 Mar 20.
Oncogene. 2017.
PMID: 28319062
Free PMC article.